More and more patients are paying more and more out of pocket for prescription drugs. The average cost of employer-based coverage is now $17,000 and patients are digger deeper and deeper into their pockets, particularly for drugs like the HCV drug, Sovaldi. – See more at: http://www.hcplive.com/contributor/arlen-meyers-md-mba/2015/09/the-new-war-on-drugs#sthash.Kopz1gE4.dpuf
Dernières nouvelles
Lisez les dernières nouvelles sur SoPE, l'innovation en matière de soins de santé et la recherche médicale